| Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) National Institutes of Health · PAR-27-078 | Public universities, Private universities | — | Oct 25, 2027 |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional) National Institutes of Health · PAR-25-353 | States, Counties, Cities & townships +12 | — | Oct 25, 2027 |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional) National Institutes of Health · PAR-25-352 | States, Counties, Cities & townships +12 | — | Oct 25, 2027 |
| Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) National Institutes of Health · PAR-25-104 | States, Counties, Cities & townships +12 | — | Oct 25, 2027 |
| Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) National Institutes of Health · PAR-25-103 | States, Counties, Cities & townships +12 | — | Oct 25, 2027 |
| Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed) National Institutes of Health · RFA-MH-27-125 | States, Counties, Cities & townships +12 | — | Oct 28, 2027 |
| National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed) National Institutes of Health · RFA-DC-28-001 | States, Counties, Cities & townships +12 | $3.6M | Nov 1, 2027 |
| Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional) National Institutes of Health · PAS-25-073 | States, Counties, Cities & townships +12 | — | Nov 5, 2027 |
| Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) National Institutes of Health · PAR-25-297 | States, Counties, Cities & townships +12 | — | Nov 5, 2027 |
| Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required) National Institutes of Health · PAR-25-149 | School districts, Housing authorities, Others | — | Nov 5, 2027 |
| BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) National Institutes of Health · RFA-DA-27-004 | States, Counties, Cities & townships +12 | — | Nov 8, 2027 |
| Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) National Institutes of Health · PAR-25-216 | States, Counties, Cities & townships +12 | — | Nov 12, 2027 |
| Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-215 | States, Counties, Cities & townships +12 | — | Nov 12, 2027 |
| NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) National Institutes of Health · PAR-24-321 | States, Counties, Cities & townships +12 | — | Nov 12, 2027 |
| Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) National Institutes of Health · PAR-25-311 | States, Counties, Cities & townships +12 | — | Nov 15, 2027 |
| Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-336 | States, Counties, Cities & townships +12 | — | Nov 15, 2027 |
| Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-068 | States, Counties, Cities & townships +12 | — | Nov 16, 2027 |
| Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) National Institutes of Health · PAR-25-266 | States, Counties, Cities & townships +12 | $200K | Nov 16, 2027 |
| Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) National Institutes of Health · PAR-25-265 | States, Counties, Cities & townships +12 | — | Nov 16, 2027 |
| Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-244 | States, Counties, Cities & townships +12 | — | Nov 16, 2027 |
| Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-122 | States, Counties, Cities & townships +12 | — | Nov 16, 2027 |
| Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) National Institutes of Health · RFA-DA-26-034 | States, Counties, Cities & townships +12 | $300K | Nov 18, 2027 |
| Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed) National Institutes of Health · RFA-DA-26-056 | States, Counties, Cities & townships +12 | — | Dec 3, 2027 |
| Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed) National Institutes of Health · RFA-DA-26-055 | States, Counties, Cities & townships +12 | — | Dec 3, 2027 |
| Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed) National Institutes of Health · RFA-HL-26-018 | States, Counties, Cities & townships +12 | — | Dec 23, 2027 |
| Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed) National Institutes of Health · RFA-HL-26-019 | States, Counties, Cities & townships +12 | — | Dec 23, 2027 |
| Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed) National Institutes of Health · RFA-HL-26-020 | States, Counties, Cities & townships +12 | — | Dec 23, 2027 |
| Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) National Institutes of Health · RFA-HL-26-016 | States, Counties, Cities & townships +12 | — | Dec 23, 2027 |
| Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) National Institutes of Health · RFA-HL-26-017 | States, Counties, Cities & townships +12 | — | Dec 23, 2027 |
| NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) National Institutes of Health · PAR-25-188 | States, Counties, Cities & townships +12 | — | Jan 6, 2028 |
| Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) National Institutes of Health · PAS-25-205 | States, Counties, Cities & townships +12 | — | Jan 6, 2028 |
| NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) National Institutes of Health · PAR-25-057 | States, Counties, Cities & townships +12 | — | Jan 6, 2028 |
| Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required) National Institutes of Health · PAR-25-062 | States, Counties, Cities & townships +12 | — | Jan 6, 2028 |
| NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-358 | States, Counties, Cities & townships +12 | — | Jan 7, 2028 |
| Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) National Institutes of Health · PAR-25-091 | States, Counties, Cities & townships +12 | — | Jan 7, 2028 |
| NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) National Institutes of Health · PAR-25-250 | States, Counties, Cities & townships +12 | — | Jan 7, 2028 |
| Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) National Institutes of Health · PAR-25-338 | States, Counties, Cities & townships +12 | $499K | Jan 7, 2028 |
| Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) National Institutes of Health · PAR-25-337 | States, Counties, Cities & townships +12 | $499K | Jan 7, 2028 |
| Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-284 | States, Counties, Cities & townships +12 | $225K | Jan 7, 2028 |
| Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) National Institutes of Health · PAR-25-283 | States, Counties, Cities & townships +12 | — | Jan 7, 2028 |
| NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) National Institutes of Health · PA-25-302 | States, Counties, Cities & townships +12 | — | Jan 7, 2028 |
| NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) National Institutes of Health · PA-25-306 | States, Counties, Cities & townships +12 | — | Jan 7, 2028 |
| NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) National Institutes of Health · PA-25-301 | States, Counties, Cities & townships +12 | — | Jan 7, 2028 |
| NIH Research Project Grant (Parent R01 Clinical Trial Required) National Institutes of Health · PA-25-305 | States, Counties, Cities & townships +12 | — | Jan 7, 2028 |
| NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) National Institutes of Health · PA-25-304 | States, Counties, Cities & townships +12 | — | Jan 7, 2028 |
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-346 | States, Counties, Cities & townships +12 | — | Jan 7, 2028 |
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) National Institutes of Health · PAR-25-321 | States, Counties, Cities & townships +12 | — | Jan 7, 2028 |
| Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) National Institutes of Health · PAR-25-298 | Public universities, Private universities, Others | — | Jan 7, 2028 |
| Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional) National Institutes of Health · PAR-25-299 | States, Counties, Cities & townships +12 | — | Jan 7, 2028 |
| NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) National Institutes of Health · PAR-25-251 | States, Counties, Cities & townships +12 | $150K | Jan 7, 2028 |